In order to tailor the site to your needs, please click the button that relates best to you.
So long as you have cookies enabled you will only need to do this once. However, you can change your selection at any time using the dropdown navigation option above the CESPHN logo, top left.
This post is not the latest immunisation update and therefore may contain information or advice that is out of date. Please see our most recent update here.
Disease notification – Which conditions are GPs required to report?
The Public Health Act 2010 requires that certain medical conditions be notified to the relevant NSW public health unit -all notifications are kept strictly confidential. All GPs are required to report notifiable conditions to their local PHU on the basis of reasonable clinical suspicion. Case notification should be initiated within 24 hours of diagnosis. Some notifiable conditions include: measles, monkeypox, and pertussis (whooping cough).
GPs must also notify the PHU by phone on 1300 066 055 if the notifiable disease is followed by a phone icon ☎ on the notification form
See National Notifiable Diseases Surveillance System NNDSS fortnightly reports for 22 August to 4 September 2022.
ANIs and RACFs now able to apply for an AIR provider number
Authorised Nurses Immunisers (ANIs) and Residential Care Facilities (RCFs) can now apply for an AIR Provider Number to access the online Australian Immunisation Register (AIR). To apply for an AIR provider number complete the IM004 form and email to MOH-VaccReports@health.nsw.gov.au
ANIs require an ABN to register for their own AIR provider number. ANIs without an ABN can be delegated AIR access from the organisation that employs them or a health professional.
Registered nurses interested in becoming a qualified ANI are encouraged to apply for CESPHN’s Nurse Scholarship to complete the training course and attain this qualification. For more information about the scholarship and to apply, see CESPHN Immunisation website. Applications close 30 September 2022. For further information, see the latest Australian Immunisation Register Update – 19 September 2022.
Monkeypox vaccine – New clinics, referral process and administration advice
Subcutaneous vs Intradermal administration
JYNNEOS monkeypox vaccine was initially administered by subcutaneous injection, however updated clinical guidance from the ATAGI now allows intradermal administration of JYNNEOS monkeypox vaccine in individuals who are not severely immunocompromised and are receiving the vaccine before exposure to monkeypox virus (pre-exposure prophylaxis). AusVaxSafety is monitoring the different vaccine delivery methods and whether there is any impact on side effects.
Referral to Mallett St clinic: GPs can provide referrals to eligible patients – the clinic will take walk-in referrals from GPs or appointments can scheduled by contacting clinic on 0460 013 803 between 9am and 4pm
Referral to Crown St clinic: GPs can directly refer eligible patients for MPX vaccination by calling Sexual Health Info Link (SHIL) on 1800 451 624
Expression of interest: patients can self-register their interest for the MPX vaccine by completing the NSW Health form
Latest MPX webinar:
Watch a recording of CESPHN’s Monkeypox webinar where PHU director Dr Vicky Sheppeard and Infectious Diseases physician Dr Kasha Singh speak about the MPX outbreak situation in CESPHN, vaccination rollout, identification, treatment, and case management.
GPs, practice nurses and pharmacists needed
Researchers at NCIRS are conducting a study to investigate the use of vaccine safety surveillance systems in order to improve and ensure they are fit-for-purpose for the needs of immunisation providers and patients.
GPs, practice nurses and pharmacists are invited to participatein a short telephone or videoconference interview to share your experiences – good, bad or non-existent – with vaccine safety surveillance systems in your daily practice. Participants will be given a voucher for their time and interviews will take place throughout October and November. Registrations close 30 October 2022.
The research was required to understand current attitudes, barriers, motivators and information needs relating to uptake of Influenza vaccines. The findings from the research will be used to inform strategic approaches to address any structural or attitudinal barriers to the uptake of influenza vaccines amongst the general population and key target audiences in future seasons.
Guidance name changed to include all COVID19 vaccine(s), not just mRNA
Updated rates of myocarditis and pericarditis following COVID-19 vaccination by age, gender, and dose
Updated evidence on the long-term outcomes of people with myocarditis or pericarditis following vaccination
Updated recommendations for revaccination in people with a history of myocarditis or pericarditis following vaccination
Third primary dose in severely immunocompromised – updated recommendations
On 23 September 2022, ATAGI recommendations on the use of a third primary dose of COVID-19 vaccine in individuals who are severely immunocompromised were updated.
What has changed:
ATAGI recommends all individuals aged 6 months and over with certain conditions or on therapies leading to severe immunocompromise to receive a 3rd primary dose of a COVID-19 vaccine.
Novavax can also be used as 3rd primary dose for Immunocompromised populations, however an mRNA COVID-19 vaccine (Pfizer or Moderna) is preferred
Webinars: Upcoming and recorded
COVID-19 response update
About: primary care update on the COVID-19 response and the vaccine rollout – key updates and Q&A
When: Thursday | 29 September 2022 | 12:00pm **note new time**
Welcome to our new website! As you may have noticed, our website looks different. Central and Eastern Sydney PHN have moved to a new site and although much has remained the same, we have introduced some new functions. These include: Updated navigation When you land on our new website, you…
COVID-19 weekly update – 02 JANUARY 2023 COVID-19 cases in the region Please note: From next week the latest COVID-19 information will be included in the Sydney Health Weekly newsletter, rather than separated at the top. We will still provide COVID-19 related information as well as the dedicated COVID-19 latest…
FIVE QUESTIONS is where we ask members of the community to talk about how they stay HEALTHY. Randwick scientist and grandmother Hilda Stender shared this: What exercise did you do yesterday? I’ve had two knee replacements – one four years ago and the other six months ago. As a result,…
Immunisation weekly update – 1 February 2023 Childhood immunisation overdue reports CESPHN is inviting general practices to sign up to receive a regular report extracted on your behalf from the Australian Immunisation Register (AIR) which is specific to your practice. This report contains all children aged 0-5 living in the CESPHN region…
Australian Digital Health Agency (ADHA) digital health webinars Implementing MyHealth Record Policies in your organisation Thu 9 Feb 23, 12.30-1.00 pm – learn how to implement and maintain a My Health Record Security and Access policy in your organisation. Understand the importance of the Responsible Officer (RO) and Organisational Maintenance…
UNSW research – Palliative care and intellectual disability A research team led by Professor Julian Trollor at the Department of Developmental Disability Neuropsychiatry, UNSW Sydney, aims to design, implement, and evaluate a new palliative care service for people with intellectual disability. This is important because people with intellectual disability often…
GP support needed: Shared e-Care plan study for follow-up of colorectal and breast cancers This research evaluates shared care using a new interactive e-care plan being implemented through cancer services in Prince of Wales and St George public and private hospitals. Through the e-care plan GPs, cancer specialists and patients…